Sex specific genotype frequencies and fitness estimates
Country of origin | NN | NH | HH | Total | Fitness NN | Fitness HH | Allele frequency N | |
---|---|---|---|---|---|---|---|---|
Healey1–6 are the data published in Healey et al.1 | ||||||||
Ishitobi refers to the data published in Ishitobi et al.6 | ||||||||
Auranen1,2 are the controls published in Auranen et al.3 | ||||||||
The fitness is relative to genotype NH and is computed separately for each sex specific group. | ||||||||
Italics indicate which data came from the original first report. | ||||||||
Females | ||||||||
Healey 1 | UK | 138 | 115 | 13 | 266 | 0.86 | 0.63 | 0.73 |
Healey 2 | UK | 631 | 493 | 77 | 1201 | 0.94 | 0.84 | 0.73 |
Healey 3 | UK | 124 | 94 | 10 | 228 | 0.88 | 0.64 | 0.75 |
Healey 4 | Germany | 433 | 373 | 60 | 866 | 0.92 | 0.81 | 0.72 |
Healey 5 | Finland | 277 | 152 | 24 | 453 | 1.03 | 1.11 | 0.77 |
Healey 6 | UK | 590 | 485 | 75 | 1150 | 0.93 | 0.81 | 0.72 |
Blood donors | UK | 192 | 172 | 25 | 389 | 0.89 | 0.73 | 0.71 |
Colon cancer controls | UK | 98 | 72 | 18 | 188 | 1.10 | 1.24 | 0.71 |
Mammography screening control women | UK | 466 | 410 | 81 | 957 | 0.97 | 0.93 | 0.70 |
Ishitobi | Japan | 95 | 56 | 3 | 154 | 0.86 | 0.43 | 0.80 |
Auranen 1 | Australia | 139 | 123 | 20 | 282 | 0.92 | 0.80 | 0.71 |
Auranen 2 | Australia | 439 | 322 | 54 | 815 | 0.98 | 0.94 | 0.74 |
Males | ||||||||
Healey 6 | UK | 644 | 435 | 116 | 1195 | 1.15 | 1.38 | 0.72 |
Blood donors | UK | 381 | 329 | 51 | 761 | 0.91 | 0.78 | 0.72 |
Colon cancer controls | UK | 115 | 95 | 21 | 231 | 1.02 | 1.05 | 0.70 |